Literature DB >> 7881735

Differential effect of sodium ions and guanine nucleotides on the binding of thioperamide and clobenpropit to histamine H3-receptors in rat cerebral cortical membranes.

E A Clark1, S J Hill.   

Abstract

1. Conflicting reports in the literature over heterogeneity (West et al., 1990) or homogeneity (Arrange et al., 1990) of histamine H3-receptor binding sites may be attributed to the use of different incubation conditions. In the present study we have investigated the extent to which the binding of H3-receptor ligands to rat cerebral cortical membranes can be modified by both sodium ions and guanine nucleotides. 2. The H3-selective antagonist, thioperamide, discriminated between two specific binding sites for [3H]-N alpha-methylhistamine (IC50 1 = 2.75 +/- 0.87 nM, IC50 2 101.6 +/- 12.0 nM, % site 1 = 24 +/- 2%) in 50 mM Tris HCl buffer, but showed homogeneity of binding in 50 mM Na/K phosphate buffer. 3. Sodium ions markedly altered the binding characteristics of thioperamide (i.e. heterogeneity was lost and IC50 value shifted towards the high affinity site). The competition curves for a second H3-antagonist, clobenpropit and the H3-agonist N alpha-methylhistamine however, were unaltered in the presence of sodium ions. 4. Guanylnucleotides displaced only 60% of specific [3H]-N alpha- methylhistamine binding and modulated thioperamide binding in the same way as sodium ions. 5. These data suggest that the H3-receptor can exist in different conformations for which thioperamide, but not N alpha-methylhistamine and clobenpropit, show differential affinity. 6. The potential nature of these sites, and the implications of this apparent receptor heterogeneity for H3-receptor antagonism by thioperamide, are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7881735      PMCID: PMC1510245          DOI: 10.1111/j.1476-5381.1995.tb13234.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Highly potent and selective ligands for histamine H3-receptors.

Authors:  J M Arrang; M Garbarg; J C Lancelot; J M Lecomte; H Pollard; M Robba; W Schunack; J C Schwartz
Journal:  Nature       Date:  1987 May 14-20       Impact factor: 49.962

2.  Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Neuroscience       Date:  1987-10       Impact factor: 3.590

3.  Frequency-dependent autoinhibition of histamine release from rat cortical slices: a possible role for H3 receptor reserve.

Authors:  A Van der Vliet; J F Van der Werf; A Bast; H Timmerman
Journal:  J Pharm Pharmacol       Date:  1988-08       Impact factor: 3.765

4.  HA autoreceptor assay with superfused slices of rat brain cortex and electrical stimulation.

Authors:  J F Van der Werf; A Bast; G J Bijloo; A Van der Vliet; H Timmerman
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.

Authors:  W N Tian; E Duzic; S M Lanier; R C Deth
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

7.  Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex.

Authors:  E Schlicker; R Betz; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

8.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

9.  A rapid filtration assay for soluble receptors using polyethylenimine-treated filters.

Authors:  R F Bruns; K Lawson-Wendling; T A Pugsley
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

10.  Autoregulation of histamine release in brain by presynaptic H3-receptors.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Neuroscience       Date:  1985-06       Impact factor: 3.590

View more
  10 in total

1.  Histaminergic neurons protect the developing hippocampus from kainic acid-induced neuronal damage in an organotypic coculture system.

Authors:  Tiina-Kaisa Kukko-Lukjanov; Sanna Soini; Tomi Taira; Kimmo A Michelsen; Pertti Panula; Irma E Holopainen
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

2.  Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.

Authors:  Florence Gbahou; Ludwig Vincent; Marie Humbert-Claude; Joel Tardivel-Lacombe; Claude Chabret; Jean-Michel Arrang
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

3.  Characterization of [(3)H]-CGP54626A binding to heterodimeric GABA(B) receptors stably expressed in mammalian cells.

Authors:  A Green; S Walls; A Wise; R H Green; A K Martin; F H Marshall
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.

Authors:  A Alves-Rodrigues; R Leurs; T S Wu; G D Prell; C Foged; H Timmerman
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Correlation of apparent affinity values from H3-receptor binding assays with apparent affinity (pKapp) and intrinsic activity (alpha) from functional bioassays.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

6.  Evidence that histamine homologues discriminate between H3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

7.  Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution.

Authors:  Po-Yuan Chen; Ching-Tsan Tsai; Che-Yen Ou; Wei-Tse Hsu; Mien-De Jhuo; Chieh-Hsi Wu; Tzu-Ching Shih; Tzu-Hurng Cheng; Jing-Gung Chung
Journal:  Mol Med Rep       Date:  2012-01-17       Impact factor: 2.952

8.  Fragment screening at adenosine-A(3) receptors in living cells using a fluorescence-based binding assay.

Authors:  Leigh A Stoddart; Andrea J Vernall; Jessica L Denman; Stephen J Briddon; Barrie Kellam; Stephen J Hill
Journal:  Chem Biol       Date:  2012-09-21

9.  A NanoBRET-Based H3R Conformational Biosensor to Study Real-Time H3 Receptor Pharmacology in Cell Membranes and Living Cells.

Authors:  Xiaoyuan Ma; Meichun Gao; Henry F Vischer; Rob Leurs
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

10.  Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism.

Authors:  Ross Corriden; Laura E Kilpatrick; Barrie Kellam; Stephen J Briddon; Stephen J Hill
Journal:  FASEB J       Date:  2014-06-26       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.